FMSNYSEServices-Misc Health & Allied Services, NECAlso trades as FMCQF
Fresenius Medical Care AG
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$21.94−0.23 (-1.04%)
Close on Oct 19, 2026
- Market cap
- $5.89B
- P/E (TTM)
- –
- Dividend yield
- –
Fresenius Medical Care AG revenue by segment
By business segment
| Revenue | TTM Q2 15 | TTM Q1 15 | TTM Q4 14 | TTM Q3 14 | TTM Q2 14 | TTM Q1 14 | TTM Q4 13 | TTM Q3 13 | TTM Q2 13 | TTM Q1 13 | TTM Q4 12 | TTM Q3 12 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Segment Total [Member] | $16.55B | $16.17B | $15.77B | $15.33B | $14.90B | $14.74B | $14.58B | $14.48B | $14.23B | $13.99B | $13.78B | $13.35B | 100.0% | +11.1% |
| Corporates [Member] | – | – | – | – | – | – | – | – | – | $21.28M | $18.97M | $14.10M | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Fresenius Medical Care's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.